Home / News

Chairman of CAIVD Song Haibo Visited Weimi to Guide the Work

2020/10/30 16:05:26 Views£º555

Chairman of CAIVD, Mr. Song Haibo invited by Weimi Bio on Oct. 22nd to guide the work. Wang Tao, general manager of Weimi greeted a warmly reception and engaged in deeply discussion as he arrived. Through the investigation to the multiple technological platform such as time resolved fluorescent tomography, Colloidal gold immunochromatograohic assay (GICA), neuroimmunity,  flow fluorescence, ELISA, chemiluminescence POCT, Song proposed significant suggestions on quality control system.

 

Chairman of CAIVD Song Haibo:

Successively served as Deputy Director of Anhui Provincial Center for Clinical Laboratories, Deputy Chairman of Anhui Micro-Improvement Society, Secretary General of Blood Transfusion Quality Management Committee of Anhui Provincial Health Bureau, Vice Chairman of National Association of Health Industry and Enterprises Management, Chairman of China Association of In Vitro Diagnostics, Secretary General of Experimental Medical Professional Committee, Standing Committee Member of the Technical Committee for Standardization of National Medical Clinical Laboratory and In Vitro Diagnostic System (TC/136), Chief Editor of www.caivd.org and www.caclp.cn, Chief Editor of the editorial board of China IVD Industry Development Year book , Editorial board member of World Journal of Complex Medicine, Chinese Journal of Primary Medicine and Pharmacy and International Journal of Laboratory Medicine and so on, Visiting professor of Tianjin Medical University and Jilin Medical College, Specially-appointed Researcher of China Medical Device Policy Research and Security Evaluation Center, Founder & CEO of CACLP

 

e2c16aa89ca2e9fab3e1eac00182e12.jpg


About Weimi Bio-Tech

Weimi Bio-Tech Co., Ltd. was established in 2013 and located in Guangzhou science city, who is devoted to high-tech field of clinical diagnostics, specializing in researching, developing, manufacturing and selling of In -Vitro Diagnostic Reagents. The company mastered core technologies of time resolved fluorescent tomography, Colloidal gold immunochromatograohic assay (GICA), neuroimmunity,  flow fluorescence, ELISA, bio-chemistry, etc. covering the series diagnosis of heart and cerebral vessels, inflammation, Obstetrics and gynecology, tumors, diabetes and nephropathy.


CAIVD WeChat
Subscription Account
CAIVD WeChat
Channels

China Association of In-vitro Diagnostics

Part of the information in our website is from the internet.

If by any chance it violates your rights, please contact us.